Bank of America Begins Coverage on Candel Therapeutics (NASDAQ:CADL)
Bank of America started coverage on shares of Candel Therapeutics (NASDAQ:CADL – Free Report) in a report released on Friday, Marketbeat reports. The brokerage issued a buy rating and a $15.00 price target on the stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $19.00 target price (up from $11.00) on shares of […]
Bank of America started coverage on shares of Candel Therapeutics (NASDAQ:CADL – Free Report) in a report released on Friday, Marketbeat reports. The brokerage issued a buy rating and a $15.00 price target on the stock. Separately, HC Wainwright reiterated a “buy” rating and issued a $19.00 target price (up from $11.00) on shares of […]
